I agree that this site is using cookies. You can find further informations here.
X
Cerezuela, P.
31  results:
Search for persons X
?
1

Fanconi-like anemia related to a FANCM mutation:

Encarnación, J.A. ; Cerezuela, P. ; Español, I....
European Journal of Medical Genetics.  65 (2022)  1 - p. 104399 , 2022
Link: https://doi.org/10.1016/..
 
?
2

PO-90 Characterization of thrombosis risk in patients with ..:

Trujillo-Santos, J. ; Salgado, M. ; García Escobar, I....
Thrombosis Research.  200 (2021)  - p. S67 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Characterization of thrombosis risk in patients with cancer:

Cerezuela, P. ; Salgado, M. ; Gallardo, E....
Thrombosis Research.  164 (2018)  - p. S236-S237 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Safety of vemurafenib in patients with BRAF V600 mutated me..:

Arance, A. M. ; Berrocal, A. ; Lopez-Martin, J. A....
Clinical and Translational Oncology.  18 (2016)  11 - p. 1147-1157 , 2016
Link: https://doi.org/10.1007/..
 
?
5

6562 POSTER First-line treatment with vinorelbine (VNR) plu..:

Galan, A. ; del Barco, S. ; Mendez, M....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 376 , 2007
Link: https://doi.org/10.1016/..
 
?
6

Weekly irinotecan plus UFT and leucovorin as first-line che..:

Méndez, M. ; Alfonso, P. G. ; Pujol, E....
Investigational New Drugs.  23 (2005)  3 - p. 243-251 , 2005
Link: https://doi.org/10.1007/..
 
?
7

A phase II study of weekly irinotecan (CPT-11) and oral ura..:

Cruz, J. ; Mendez, M. ; Alfonso, P....
European Journal of Cancer.  37 (2001)  - p. S295 , 2001
Link: https://doi.org/10.1016/..
 
?
8

PO-1557 RT after Encorafenib and Binimetinib on BRAF mutate..:

Alvarez, A. ; Valduvieco, I. ; Arance, A....
Radiotherapy and Oncology.  182 (2023)  - p. S1264 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Mitotic rate as an important prognostic factor in cutaneous..:

Piñero-Madrona, A. ; Ruiz-Merino, G. ; Cerezuela Fuentes, P....
Clinical and Translational Oncology.  21 (2019)  10 - p. 1348-1356 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Preemptive Therapy for Cytomegalovirus Disease in Allogenei..:

de la Cruz-Vicente, F. ; Cerezuela Martinez, P. ; Gil-Espárraga, E....
Transplantation Proceedings.  40 (2008)  9 - p. 3102-3103 , 2008
Link: https://doi.org/10.1016/..
 
?
11

Multidisciplinary development of the Geriatric Core Dataset..:

Maria-José, M.G. ; Sánchez-Castellano, C. ; Cano, J.M. Cano...
Journal of Geriatric Oncology.  14 (2023)  8 - p. S58 , 2023
Link: https://doi.org/10.1016/..
 
?
12

7049 Early results of a phase II trial of second line chemo..:

Blesa, J. Gasent ; Candel, V. Alberola ; Vidal, O. Juan..
European Journal of Cancer Supplements.  7 (2009)  2 - p. 421 , 2009
Link: https://doi.org/10.1016/..
 
?
13

7050 Evidence of psa decrease with fulvestrant acetate in a..:

Blesa, J. Gasent ; Candel, V. Alberola ; Vidal, O. Juan..
European Journal of Cancer Supplements.  7 (2009)  2 - p. 421 , 2009
Link: https://doi.org/10.1016/..
 
?
14

SARS-CoV-2 infection in patients with melanoma: results of ..:

Gonzalez-Cao, M. (María) ; Puertolas, T. (Teresa) ; Martínez-Vila, C. (Clara)...
https://hdl.handle.net/10171/65982.  , 2023
Link: https://hdl.handle.net/1..
 
?
15

Frequency and characteristics of familial melanoma in Spain..:

Marques-Rodas, I. (Iván) ; Martin-Gonzalez, M. (Manuel) ; Nagore, E. (Eduardo)...
https://hdl.handle.net/10171/38273.  , 2015
Link: https://hdl.handle.net/1..
 
1-15